GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC11745 structure
    GC11745S-(2-aminoethyl) Isothiourea (dihydrobromide)
    CAS: 56-10-0
    Purity: >98%

    non-selective inhibitor of all NOS isoforms

  • GC11751 structure
    GC11751QNZ (EVP4593)
    CAS: 545380-34-5
    Purity: >98.00%

    QNZ (EVP4593) est un inhibiteur hautement puissant et sélectif de la voie de signalisation du facteur nucléaire κB (NF-κB), sa valeur d'IC50 est 11nM et il présente des effets anti-inflammatoires.

  • GC11770 structure
    GC11770Ketone Ester
    CAS: 1208313-97-6
    Purity: >99.50%

    A ketone ester with anti-obesity and anticonvulsant activities

  • GC11786 structure
    GC11786Acetylcysteine
    CAS: 616-91-1
    Purity: >99.00%

    Acetylcysteine est un dérivé N-acétylé de la L-cystéine et un précurseur du gluathion. Elle possède une activité mucolytique.

  • GC11800 structure
    GC11800SB 290157 (trifluoroacetate salt)
    CAS: 1140525-25-2
    Purity: >99.50%

    SB 290157 (trifluoroacetate salt) est utilisé comme antagoniste sélectif non peptidique du récepteur C3a.

  • GC11817 structure
    GC11817PDM 2
    CAS: 688348-25-6
    Purity: >98.50%

    Le PDM 2 est un antagoniste sélectif des récepteurs d'aryle hydrocarbure (AhR) de haute affinité avec un Ki de 1,2 ± 0,4 nM.

  • GC11866 structure
    GC11866Cyclosporin D
    CAS: 63775-96-2
    Purity: >98%

    La cyclosporine D, un métabolite de la cyclosporine A, est un immunosuppresseur faible.

  • GC11867 structure
    GC11867(S)-Lisofylline
    CAS: 100324-80-9
    Purity: >98%

    inactive optical enantiomer of (R)-LSF, an anti-inflammatory agent

  • GC12040 structure
    GC12040L-Kynurenine
    CAS: 2922-83-0
    Purity: >98.00%

    L-Kynurenine est un métabolite du L-tryptophane et un agoniste du récepteur des hydrocarbures aromatiques (AhR).

  • GC12070 structure
    GC12070Ascorbic acid (Standard)
    CAS: 50-81-7
    Purity: >98.00%

    Un donneur d'électrons

  • GC12114 structure
    GC12114Oxaprozin
    CAS: 21256-18-8
    Purity: >99.50%

    L'oxaprozine est un inhibiteur de COX actif et puissant par voie orale, avec des valeurs d'IC50 de 2,2 μM pour la COX-1 plaquettaire humaine et de 36 μM pour la cellule synoviale humaine COX-2 stimulée par l'IL-1, respectivement.

  • GC12159 structure
    GC12159HZ52
    CAS: 1077626-51-7
    Purity: >98%

    HZ52 est un puissant inhibiteur réversible de la 5-lipoxygénase, bloquant la synthèse des leucotriènes avec une IC50 de 0,7 μM dans les leucocytes polymorphonucléaires humains intacts .

  • GC12166 structure
    GC121662-Iminopiperidine hydrochloride
    CAS: 16011-96-4
    Purity: >98%

    iNOS inhibitor

  • GC12203 structure
    GC12203L-Glutathione Reduced
    CAS: 70-18-8
    Purity: >97.00%

    Utilisé pour éluer la GST de l'agarose de glutathion.

  • GC12205 structure
    GC12205PD 146176
    CAS: 4079-26-9
    Purity: >98.00%

    PD 146176 est l'un des inhibiteurs puissants et sélectifs de 15-LOX-1 des réticulocytes.

  • GC12232 structure
    GC12232BAY-X 1005
    CAS: 128253-31-6
    Purity: >98.50%

    BAY-X 1005 (BAY X 1005; DG-031) est un inhibiteur de la protéine activatrice de la 5-lipoxygénase (FLAP) actif et sélectif par voie orale.

  • GC12277 structure
    GC12277MK 886
    CAS: 118414-82-7
    Purity: >99.50%

    MK 886 (L 663536) est un inhibiteur puissant, perméable aux cellules et oralement actif de la biosynthèse des FLAP (IC50 de 30 nM) et des leucotriènes (IC50 de 3 nM et 1,1 μM dans les leucocytes intacts et le sang total humain). MK 886 est également un antagoniste non compétitif de PPARα et peut induire l'apoptose.

  • GC12288 structure
    GC12288GSK-J1 sodium salt
    CAS: 1797832-71-3
    Purity: >98%

    A neuropeptide with diverse biological activities

  • GC12309 structure
    GC123097-Nitroindazole
    CAS: 2942-42-9
    Purity: >98%

    Le 7-nitroindazole est un inhibiteur sélectif de la nNOS avec des effets antinociceptifs et cardiovasculaires.

  • GC12325 structure
    GC12325BYK 191023 dihydrochloride
    CAS: 1216722-25-6
    Purity: >98%

    INOS inhibitor,potent and selective

  • GC12330 structure
    GC12330SAR191801
    CAS: 1234708-04-3
    Purity: >99.50%

    SAR191801 est un inhibiteur de hPGDS, avec IC50 de 12 nM dans le test de polarisation de fluorescence ou le test EIA.

  • GC12331 structure
    GC12331JC-1
    CAS: 3520-43-2
    Purity: >99.50%

    JC-1(CBIC2) est un colorant fluorescent carbonyl cyanine cationique.

  • GC12342 structure
    GC12342NDT 9513727
    CAS: 439571-48-9
    Purity: >99.00%

    NDT 9513727 est un agoniste inverse puissant, sélectif, actif par voie orale et compétitif du C5aR humain (récepteur C5a), avec une IC50 de 11,6 nM.

  • GC12370 structure
    GC12370IKK-16 (hydrochloride)
    CAS: 1186195-62-9
    Purity: >98%

    IKK-16 (hydrochloride) est un nouvel inhibiteur sélectif de la kinase IκB (IKK) actif par voie orale, dont les valeurs d'IC50 sont 40nM, 70nM, et 200nM vis-à-vis de IKK-2, complexe IKK , et IKK-1.